A longitudinal study of BDNF promoter methylation and depression in breast cancer

Psychiatry Investigation

Volumn 12, Issue 4, 2015, Pages 523-531

  Kang, Hee Ju ^a   Kim, Jae Min ^a   Kim, Seon Young ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Kim, Hye Ran ^a   Park, Min Ho ^b   Shin, Myung Geun ^a   Yoon, Jung Han ^b   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

BDNF; Breast cancer; Depression; DNA methylation; Epigenetics

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CPG ISLAND; DEPRESSION; DISEASE SEVERITY; DNA METHYLATION; DSM-IV; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PROMOTER REGION; QUESTIONNAIRE; SCORING SYSTEM;

EID: 84946554642     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2015.12.4.523     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Bower J. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 2008;26:768-777.
4. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005;330:702.
5. Shim EJ, Shin YW, Jeon HJ, Hahm BJ. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology 2008;17:548-555.
6. Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 2005;23:3052-3060.
7. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008;30:112-126
8. Weinberger T, Forrester A, Markov D, Chism K, Kunkel EJ. Women at a dangerous intersection: diagnosis and treatment of depression and related disorders in patients with breast cancer. Psychiatr Clin North Am 2010;33:409-422.
9. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-420.
10. Kim JM, Kim SW, Stewart R, Kim SY, Shin IS, Park MH, et al. Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer. Psychosom Med 2012;74:8-15.
11. Kim JM, Stewart R, Kim SY, Kang HJ, Jang JE, Kim SW, et al. A one year longitudinal study of cytokine genes and depression in breast cancer. J Affect Disord 2013;148:57-65.
12. Fingeret MC, Nipomnick SW, Crosby MA, Reece GP. Developing a theoretical framework to illustrate associations among patient satisfaction, body image and quality of life for women undergoing breast reconstruction. Cancer Treat Rev 2013;39:673-681.
13. Safarinejad MR, Shafiei N, Safarinejad S. Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psychooncology 2013;22:1242-1248.
14. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic Sensitivity to the Environment: the Case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010;167:509-527.
15. Huang EJ, Reichardt LF. Neutrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-736.
16. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
17. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging 2008;29:789-792.
18. Zhou JX, Li HC, Bai XJ, Chang BC, Li CJ, Sun P, et al. Functional Val66Met polymorphism of Brain derived neurotophic factor in type 2 diabetes with depression in Han Chinese subjects. Behav Brain Funct 2013;9:34.
19. Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, et al. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 2009;24:813-818.
20. Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, et al. Child health, developmental plasticity, and epigenetic programming. Endocr Rev 2011;32:159-224.
21. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, et al. DNA methylation related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003;302:890-893.
22. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 2011;6:e23881.
23. Kim JM, Stewart R, Kang HJ, Kim SY, Kim SW, Shin IS, et al. A longitudinal study of BDNF promoter methylation and genotype with poststroke depression. J Affect Disord 2013;149:93-99.
24. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005;136:29-37.
25. Devlin AM, Brain U, Austin J, Oberlander TF. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 2010;5:e12201.
26. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-VI and ICD-10. J Clin Psychiatry 1998;59(suppl 20): 22-33.
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
28. Lindesay J. The Guy's/Age Concern Survey: physical health and psychiatric disorder in an urban elderly community. Int J Geriatr Psychiatry 1990;5:171-178.
29. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Handbook from the AJCC Cancer Staging Manual. 6th Edition. New York: Springer-Verlag, 2002, p.257-281.
30. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8:355-367
31. Mill J, Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry 2007;12:799-814.
32. Schroeder M, Krebs MO, Bleich S, Frieling H. Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry 2010;23:588-592.
33. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W, Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008;147B:543-549.
34. Zill P, Baghai TC, Schüle C, Born C, Früstück C, Büttner A, et al. DNA methylation analysis of the Angiotensin Converting Enzyme (ACE) gene in major depression. PLoS One 2012;7:e40479.
35. Kang HJ, Kim JM, Stewart R, Kim SY, Bae KY, Kim SW, et al. Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry 2013;44:23-28.
36. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Association between promoter methylation of serotonin transpoter gene and depressive symptoms: a monozygotic twin study. Psychosom Med 2013;75:523-529.
37. Powell TR, Smith RG, Hackinger S, Schalkwyk LC, Uher R, McGuffin P, et al. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Transl Psychiatry 2013;3:e300.
38. Xu J, Cheng YQ, Chen B, Bai R, Li S, Xu XF, et al. Depression in systemic lupus erythematosus patients is associated with link-polymorphism but not methylation status of the 5HTT promoter region. Lupus 2013; 22:1001-1010.
39. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270: 593-598.
40. Kim JM, Stewart R, Kang HJ, Kim SW, Shin IS, Kim HR, et al. A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression. J Psychiatr Res 2013;47:1222-1227.
41. Niitsu T, Fabbri C, Bentini F, Serretti A. Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:183-194.
42. Pei Y, Smith AK, Wang Y, Pan Y, Yang J, Chen Q, et al. The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2012;159B:560-566.
43. Henningsson S, Borg J, Lundberg J, Bah J, Lindström M, Ryding E, et al. Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. Biol Psychiatry 2009;66:477-485.
44. Philibert RA, Madan A, Andersen A, Cadoret R, Packer H, Sandhu H. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet 2007;144B:101-105.
45. Kinnally EL, Capitanio JP, Leibel R, Deng L, LeDuc C, Haghighi F, et al. Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques. Genes Brain Behav 2010;9:575-582.
46. Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 2008; 110:9-17.
47. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012;13:R43.
48. Pidsley R, Mill J. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 2011;69:146-156.
49. Melas PA, Rogdaki M, Lennartsson A, Björk K, Qi H, Witasp A, et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 2012;15:669-679.